Related Experiment Video
Updated: Jan 31, 2026

Author Spotlight: Advancing Gene Editing in Bamboo Leaves for Sustainable Plastic Alternatives
Published on: August 18, 2023
Evaluation of the bitter components of bamboo shoots using a metabolomics approach
Quan Gao1, Hao Jiang, Feng Tang
1Anhui Key Laboratory of Agricultural Products, School of Plant Protection, Anhui Agricultural University, Hefei 230036, China.
Abstract:
Bamboo shoots, most of which are bitter in taste, are a traditional vegetable eaten in Asia. However, our understanding of the components responsible for this bitterness is limited. In this study, we used metabolomic and phytochemical analyses to scientifically study bamboo shoot bitterness. Based on oral evaluation, 16 common bamboo shoots were categorized into four bitterness groups. The most bitter species was Pleioblastus amarus. Thus, we isolated and performed a detailed spectroscopic analysis of 14 main compounds from this species. The correlation between the concentration of these components and bitterness in four representative bamboo shoot species was then analyzed by UPLC-MRM-MS and PLS-DA. It appears that bamboo shoot bitterness is largely due to l-phenylalanine, uridine, l-omithine, l-tryptophan, and adenine, with l-phenylalanine being the greatest contributor. In addition to identifying the primary component involved in bamboo shoot bitterness, this study also outlines a novel method for evaluating the bitterness of natural foods.
Related Concept Videos
Primary and Secondary Growth in Roots and Shoots
Components of Stress
Interestingly, the hidden cube faces also experience these stresses, equal and...
Components of Language
Vector Algebra: Method of Components
In many applications, the magnitudes and directions of...
Curvilinear Motion: Rectangular Components
As the car advances, its position evolves over time. Quantifying the car's velocity involves computing the...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...

